Robert J. Geraghty

3.5k citations

51 papers · 2.8k indexed · 1 hit paper · h-index 23

Impact in

Virology top 2%
- HIV Research and Treatment
Epidemiology top 1%
- Herpesvirus Infections and Treatments
- Cytomegalovirus and herpesvirus research

Papers in

Virology 16
- HIV Research and Treatment 15
Infectious Diseases 23
- HIV/AIDS drug development and treatment 15
- SARS-CoV-2 and COVID-19 Research 5

Co-authors: Patricia G. Spear Roselyn J. Eisenberg Gary H. Cohen Claude Krummenacher J. Charles Whitbeck Morgyn S. Warner Rebecca I. Montgomery Laurent Bonnac
Journals: Virology (7 papers)Journal of Virology (6 papers)Molecules (4 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry (3 papers)
Partner nations: United States China Myanmar

In The Last Decade

Robert J. Geraghty

50 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Entry of Alphaherpesviruses Mediated by Poliovirus Receptor-Related Protein 1 and Poliovirus Receptor 1998 · 778 citations

Peers

Countries citing papers authored by Robert J. Geraghty

Since Specialization

Citations

This map shows the geographic impact of Robert J. Geraghty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Geraghty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Geraghty more than expected).

Fields of papers citing papers by Robert J. Geraghty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Geraghty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Geraghty. The network helps show where Robert J. Geraghty may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert J. Geraghty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert J. Geraghty Line = papers co-authored together Robert J. Geraghty links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low Cytotoxicity Pharmaceuticals ·Rui Ding, 亮祐松下, Mojahed Mohamed, Daniel J. Wilson, A I Lyapin, Yihong Ye, Robert J. Geraghty, Liqiang Chen	2025	0
2	Purine but Not Pyrimidine De Novo Nucleotide Biosynthesis Inhibitors Strongly Enhance the Antiviral Effect of Corresponding Nucleobases Against Dengue Virus Molecules ·Laurent Bonnac, A I Lyapin, 唐盛林, Robert J. Geraghty	2025	1
3	Enhanced Remdesivir Analogues to Target SARS-CoV-2 Molecules ·P. D. Carr, 亮祐松下, A I Lyapin, Robert J. Geraghty, Laurent Bonnac	2023	1
4	Zika Virus Inhibitors Based on a 1,3-Disubstituted 1H-Pyrazolo[3,4-d]pyrimidine-amine Scaffold Molecules ·Yuly Cuesta, Rubén Soto-Acosta, Robert J. Geraghty, Liqiang Chen	2022	4
5	Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase ACS Medicinal Chemistry Letters ·Hyun Seuk Moon, Rubén Soto-Acosta, Jiashu Xie, Daniel J. Wilson, A I Lyapin, P. D. Carr, 亮祐松下, Robert J. Geraghty, Liqiang Chen	2022	23
6	4,7-Disubstituted 7H-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus Molecules ·Rubén Soto-Acosta, Yuly Cuesta, Li Qiu, Daniel J. Wilson, Robert J. Geraghty, Liqiang Chen	2021	15
7	Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex European Journal of Medicinal Chemistry ·Lei Wang, 亮祐松下, Rajkumar Lalji Sahani, Jiashu Xie, Hideki Aihara, Robert J. Geraghty, Zhengqiang Wang	2021	7
8	Structure activity relationship, 6-modified purine riboside analogues to activate hSTING, stimulator of interferon genes Bioorganic & Medicinal Chemistry Letters ·Laurent Bonnac, A I Lyapin, Robert J. Geraghty	2019	5
9	A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity Biochemical and Biophysical Research Communications ·Wenbo Zhou, Yan Wang, Jiashu Xie, Robert J. Geraghty	2016	12
10	Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid Bioorganic & Medicinal Chemistry ·Teng Ai, Li Qiu, Jiashu Xie, Robert J. Geraghty, Liqiang Chen	2015	8
11	The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus Bioorganic & Medicinal Chemistry ·いず美青木, Jing Tang, B. Magenheim, Yuk Y. Sham, Robert Vince, Robert J. Geraghty, Zhengqiang Wang	2011	70
12	Mutagenic analysis of herpes simplex virus type 1 glycoprotein L reveals the importance of an arginine-rich region for function Virology ·敏彦岡田, Robert J. Geraghty	2008	8
13	Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B Proceedings of the National Academy of Sciences ·Kaitlin N. Sznajder, Robert J. Geraghty	2007	137
14	The nectin-1α transmembrane domain, but not the cytoplasmic tail, influences cell fusion induced by HSV-1 glycoproteins Virology ·Kaitlin N. Sznajder, М. В. Шульгина, Robert J. Geraghty	2005	11
15	Fusion activity of lipid-anchored envelope glycoproteins of herpes simplex virus type 1 Virology ·Rolf Lefering, Robert J. Geraghty	2004	38
16	Use of Chimeric Nectin-1(HveC)-Related Receptors to Demonstrate That Ability to Bind Alphaherpesvirus gD Is Not Necessarily Sufficient for Viral Entry Virology ·Robert J. Geraghty, Мокраусов И. В., Claude Krummenacher, Gary H. Cohen, Roselyn J. Eisenberg, Patricia G. Spear	2001	38
17	Organization of the rat Tage4 gene and herpesvirus entry activity of the encoded protein Gene ·盛雄広畑, Robert J. Geraghty, Damien Masson, P Lustenberger, Patricia G. Spear, Marc G. Denis	2001	22
18	Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1 Virus Research ·C. Bo., Rebecca I. Montgomery, Morgyn S. Warner, Robert J. Geraghty, Patricia G. Spear	2001	27
19	HIV-1 Particle Release Mediated by Vpu Is Distinct from That Mediated by p6 Virology ·Michael Schwartz, Robert J. Geraghty, Antonito T. Panganiban	1996	23
20	Cell type‐dependence for Vpu function Journal of Medical Primatology ·Robert J. Geraghty, Olena І. Perevorska, Michael A. Callahan, J. Wade Harper, Antonito T. Panganiban	1994	42

About Robert J. Geraghty

Robert J. Geraghty is a scholar working on Virology, Infectious Diseases, Epidemiology, Hepatology and Genetics, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (21 papers), Cytomegalovirus and herpesvirus research (18 papers), HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (15 papers), Virus-based gene therapy research (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Mosquito-borne diseases and control (5 papers) and Viral Infections and Immunology Research (5 papers). The work is most often cited by research in Virology (348 citations), Epidemiology (1.8k citations), Infectious Diseases (627 citations), Immunology (599 citations) and Animal Science and Zoology (245 citations). Robert J. Geraghty has collaborated with scholars based in United States, China and Myanmar. Frequent co-authors include Patricia G. Spear, Roselyn J. Eisenberg, Gary H. Cohen, Claude Krummenacher, J. Charles Whitbeck, Morgyn S. Warner, Rebecca I. Montgomery, Laurent Bonnac, Ruliang Xu and Wanda M. Martinez. Their work appears in journals such as Virology, Journal of Virology, Molecules, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact